Track early signs of generic competition

View a screenshot Click on the thumbnail to view a full-size example screen.

Spot the developing generic competition. Find the opportunity

Newport Vision CI™ is the critical competitive intelligence and global business development system from Thomson Scientific, the industry authority on the global generics market.

Created specifically for research-based innovator, specialty and niche-brand pharmaceutical companies, it ensures you don’t miss the developing generic competition that can impact your sales, or the opportunity that can build on your strengths.

Newport Vision CI incorporates the unique strategic intelligence and powerful competitive analysis that is only available from Thomson Scientific. It continually tracks, monitors and expertly analyzes ongoing developments in more than 10,000 launched products and 12,000 companies operating in the global pharmaceutical market.

Its proven analytics can warn of potential generic activity four to seven years ahead of loss of exclusivity.

With its sophisticated targeting capabilities,
Newport Vision CI can help you to identify, profile and evaluate licensing, acquisition and partnership opportunities in launched and approved products worldwide.

You can discover the niche opportunities that match your strategic needs and unique strengths in research, sales or marketing.

Further information

Click here to download the Newport Vision CI fact sheet